Company facts
- Industry
- Hospital & Medical Service Plans
- Headquarters
- Bloomfield, Connecticut
- Most recent report
- 10-Q, filed Jul 30, 2026
- Incorporated
- Delaware
- Filings on record
- 1,002+ filings
- On EDGAR
- CIK 1739940
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 31
News 8 of 133
- 8-K Quarterly results Jul 30, 2026
- 8-K Current report on a material event May 13, 2026
- 8-K Quarterly results Apr 30, 2026
- 8-K Shareholder vote results Apr 27, 2026
- 8-K Leadership change Mar 3, 2026
- 8-K Current report on a material event Feb 27, 2026
- 8-K Quarterly results Feb 5, 2026
- 8-K Other events Nov 18, 2025
Prospectuses and Registrations 8 of 26
- 424B5 Prospectus supplement for an offering Sep 4, 2025
- FWP Free writing prospectus Sep 3, 2025
- 424B5 Prospectus supplement for an offering Sep 2, 2025
- S-3ASR Automatic shelf registration Sep 2, 2025
- 424B5 Prospectus supplement for an offering Feb 7, 2024
- FWP Free writing prospectus Feb 6, 2024
- 424B3 Prospectus supplement for an offering Feb 5, 2024
- 424B5 Prospectus supplement for an offering Mar 2, 2023
Proxies 8 of 35
- DEFA14A Extra proxy material Mar 13, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 13, 2026
- DEFA14A Extra proxy material Mar 14, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 14, 2025
- DEFA14A Extra proxy material Apr 12, 2024
- PX14A6G Shareholder's own proxy material Apr 11, 2024
- DEFA14A Extra proxy material Apr 5, 2024
- DEFA14A Extra proxy material Mar 15, 2024
Ownership 8 of 750
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 3, 2026
- 144 Notice of a proposed sale of restricted stock Sep 3, 2026
- 4 Insider reported a trade Sep 2, 2026
- 4 Insider reported a trade Aug 20, 2026
- 4 Insider reported a trade Aug 20, 2026
- 144 Notice of a proposed sale of restricted stock Aug 18, 2026
- 4 Insider reported a trade Aug 6, 2026
Other 8 of 27
- 11-K Employee stock plan report Jun 24, 2026
- ARS Annual report sent to shareholders Mar 13, 2026
- 11-K Employee stock plan report Jun 27, 2025
- ARS Annual report sent to shareholders Mar 14, 2025
- UPLOAD Comment letter from SEC staff Jan 29, 2025
- CORRESP Reply to SEC staff Jan 16, 2025
- UPLOAD Comment letter from SEC staff Dec 20, 2024
- CORRESP Reply to SEC staff Nov 21, 2024
What to read: Jun 2026 10-Q
SECSift found 2 of 11 sections worth reading, with 0 positive, 7 notable, and 0 negative flags.
Financial Statements (Item 1)
Core financial statements with real results, charges, new disclosures - essential reader content.Notable- Cigna announced planned exit from Individual and Family Plans business as of Jan 1, 2027.
- New factoring facility added; $0.9B of sold receivables uncollected at June 30, 2026.
- Commercial paper outstanding of $1.0B at June 30, 2026 (was $0 at March 31, 2026).
- Strategic optimization program costs $450M in H1 2026; program-to-date total $1,199M pre-tax.
- CODM changed from Chair and CEO to President and CEO.
Management's Discussion (Item 2)
Segment results, strategic exit, buyback slowdown, cash flow details.
What changed: Jun 2026 vs. Mar 2026
About 6% of CI's Jun 2026 10-Q is new information. 18 paragraphs were added, 137 changed, and 28 removed. Below are the most important lines SECSift identified.
Changed
Removed
Everything here comes from Cigna Group's own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Aug 20, 2026, from the 10-Q for Jun 2026.